サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1756448

CRISPRベース診断の世界市場：製品別・技術別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

CRISPR-Based Diagnostics Market, By Product, By Technology, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
CRISPRベース診断の世界市場：製品別・技術別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年05月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

CRISPRベース診断の市場規模は2024年に31億233万米ドルとなり、2025年から2032年にかけてCAGR 16.93%で拡大

CRISPRベース診断の市場力学

CRISPRベース診断市場は、世界の感染症負担の増加によって牽引されています。感染症による死亡者数は年間1,000万人を超えると推定されており（WHOによる）、迅速かつ正確な診断ツールが必要とされています。さらに、遺伝性疾患やがんの発生率が世界的に上昇していることも、早期発見やオーダーメイド医療のための正確な診断アプローチの必要性を高めています。米国国立衛生研究所（NIH）によれば、遺伝性疾患は世界中で数百万人の犠牲者を出しており、がんは主要な死因となっています。CRISPR診断法は、特定の遺伝子変異やがんのバイオマーカーを高い特異性で検出できる可能性があります。ポイント・オブ・ケア（POC）診断法は、資源の乏しい環境での迅速な検査結果や分散化された検査の必要性から、ますます需要が高まっています。CRISPRベースアッセイは、使いやすいPOC装置用に改良することが可能であり、流行地域やアウトブレイク時の診断に変革をもたらす可能性があります。

特異性と活性が向上した新しいCAS酵素の同定、アッセイデザインとシグナル増幅法の進歩など、CRISPRシステムにおける技術の進歩は、CRISPRに基づく診断の能力と範囲を漸進的に向上させる。感染症や遺伝性疾患からがんに至るまで、様々な疾患カテゴリーにわたる幅広いアプリケーションは、巨大な潜在市場を提示しています。単一の反応内で複数のターゲットを並行して検出するマルチプレックスアッセイを作製する能力は、経済性と効率性において大きなアドバンテージとなります。加えて、CRISPR診断法とマイクロ流体工学やその他の最先端技術との融合は、非常に高感度で自動化された診断プラットフォームを生み出す可能性があります。ゲノミクスと診断学における研究開発への支出の増加は、政府および民間セクターの資金援助も含め、市場の拡大と技術革新の原動力となっています。しかしながら、認可の障壁や標準化の必要性は、これらの新技術の普遍的な普及を阻む障害となっています。

CRISPRベース診断市場：主な考察

CRISPRベース診断アッセイでは消耗品が継続的に必要とされるため、試薬とキットのセグメントが最大です。より多くの調査と診断テストは、ガイドRNA、Cas酵素、その他の試薬を必要とするキットの一貫した需要につながります。

Cas9は、CRISPRベース診断において、最も研究され、最も広く使用されているCas酵素であり、その理由は、メカニズムが十分に解明されており、ツールやリソースが豊富にあり、汎用性が高いからです。

病院や診断検査室は、CRISPRベース診断の最大の消費者です。その理由は、既存のインフラ、ハイスループット検査能力、無数の疾患の検出のための最先端の分子診断法の利用が増加しているためです。

製薬企業やバイオテクノロジー企業は、医薬品開発、臨床試験、品質管理のためにCRISPRベース診断をますます利用するようになっています。

北米がCRISPRベース診断市場で最大のシェアを占めています。これは、北米に著名な研究施設、著名なバイオテクノロジーおよび製薬組織が多く存在し、診断およびゲノミクスの研究に多額の政府資金が投入されているためです。

CRISPRベース診断市場：セグメンテーション分析

世界のCRISPRベース診断市場は、製品、技術、用途、最終用途、地域に基づいてセグメント化されます。

技術別では、市場はCas9、Cas12、その他に区分されます。Cas9セグメントが最大の市場シェアを持っています。これは、Cas9が最も広く研究され、最もよく理解されているCRISPR関連酵素であることが主な理由です。その強力で多様なDNA標的化能力により、市場の黎明期に開発された数多くの診断アプリケーションの主力となりました。Cas9に基づくツール、試薬、および標準化されたプロトコルの大規模なコレクションが利用可能であるため、研究および診断開発における広範な応用が可能です。さらに、Cas9ベースの診断テストの早期達成と確立は、その支配的な役割を再確認しました。Cas12コンポーネントは市場で最も急速に開拓されています。これは、crRNAアレイを消化する能力やユニークなssDNAトランス切断活性など、Cas12酵素が提供する特別な強みによって推進されています。この後者の能力は、Cas9ベースのアプローチよりも高い感度と容易なアッセイデザインを提供することができます。より優れた特性を持つ新規のCas12変異体の継続的な同定と、ポイントオブケア診断における潜在的なアプリケーションの研究の高まりが、急速な成長率を牽引しています。

アプリケーションに基づき、市場は感染症診断、遺伝子疾患診断、がん診断、その他に区分されます。感染症診断薬市場は最大のシェアを占めています。これは、感染性病原体の迅速かつ正確な同定に対する世界の需要が後押ししています。CRISPRベース診断は、最近のパンデミックの際に見られたように、新規および新興の感染性病原体の検出に迅速に再利用できることから、アウトブレイク対策や患者ケアの強化において重要な役割を担っています。ポイント・オブ・ケア診断の可能性や、微量のウイルスや細菌を検出する感度の高さも、この分野を支配する要因となっています。がん診断薬は、市場で最も急速に成長している分野です。この背景には、世界のがん罹患率の上昇と、患者の予後を改善するためのより早期かつ正確な診断ツールの必要性があります。感度と特異性に優れたCRISPR技術は、リキッドバイオプシーにおける循環腫瘍DNA（ctDNA）など、がん特異的バイオマーカーの検出に大きな可能性をもたらします。これにより、がんの早期発見、治療効果のモニタリング、個別化がん治療に革命が起こる可能性があります。

CRISPRベース診断市場：地域別分析

北米が最大の市場シェアを占めています。この地域の強力な研究基盤、CRISPR技術の進歩に積極的に貢献している多くの大手バイオテクノロジー企業や製薬企業、ゲノム・診断研究に対する膨大な政府支援が、この地域優位の背景にあります。また、北米の強力なヘルスケア・インフラと高度な分子診断法の高い普及率も追加的な要因となっています。この地域市場の主要国は、先端研究と商業化の中心地である米国と、バイオテクノロジーとヘルスケア革新に重点を置くようになっているカナダです。アジア太平洋は、CRISPRベース診断薬の市場開拓が最も急速に進むと予想されます。この成長は、この地域の膨大な人口における感染症や遺伝性疾患の発生率の増加、医療支出の増加、高度な診断技術に対する認識と受容の増加、中国、インド、韓国などの国々における研究開発への投資の増加など、さまざまな要因によってもたらされます。

CRISPRベース診断市場：競合情勢

CRISPRベース診断市場は、既存のライフサイエンス企業、重点的な診断開発企業、最先端の新興企業が混在し、急速に進化する競合環境が特徴です。主要企業は、診断におけるCRISPR技術の有用性の拡大、アッセイ感度と特異性の向上、便利でポイントオブケアに基づくソリューションの創出を目的とした研究開発を継続的に行っています。戦略的提携、パートナーシップ、ライセンシングは、各社が相互補完的な能力を活用し、製品開発と商業化を促進するために一般的に行われています。新しいCRISPR-Casシステムと新しいアッセイフォーマットの継続的な特定が、競争圧力をさらに高めています。各社は、製品革新、技術革新、共同研究、規制経路のインテリジェントなナビゲーションを基に差別化を図っています。感染症、がん、遺伝性疾患など様々な用途に向けた、積極的で信頼性が高く、スケーラブルなCRISPRベース診断プラットフォームの開発は、この新たな競合環境におけるライトモチーフです。

目次

第1章 CRISPRベース診断市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 CRISPRベース診断の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 CRISPRベース診断市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 CRISPRベース診断市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 CRISPRベース診断の市場情勢

  • CRISPRベース診断の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 CRISPRベース診断市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 酵素
    • キット・試薬
    • ソフトウェア・ライブラリ

第8章 CRISPRベース診断市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • Cas9
    • Cas12
    • その他

第9章 CRISPRベース診断市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 感染症診断
    • 遺伝性疾患診断
    • がん診断
    • その他

第10章 CRISPRベース診断市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院・診療所の診断
    • 研究所
    • 製薬・バイオテクノロジー企業
    • その他

第11章 CRISPRベース診断市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：CRISPRベース診断業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Integrated DNA Technologies, Inc.
    • Molbio Diagnostics
    • Horizon Discovery
    • Synthego Corporation
    • Mammoth Biosciences
    • Sherlock Biosciences
    • Caribou Biosciences
    • CrisprBits
    • ToolGen Inc.

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV5280

REPORT HIGHLIGHT

CRISPR-Based Diagnostics Market size was valued at US$ 3,102.33 Million in 2024, expanding at a CAGR of 16.93% from 2025 to 2032.

CRISPR diagnostics are a ground breaking category of molecular diagnostic technologies that utilize the accuracy and programmability of the clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (CAS) protein systems. These new technologies are novel alternatives and supplements to conventional diagnostic approaches, promising the ability to detect a broad range of analytes through rapid, sensitive, specific, and cost-efficient analysis. CRISPR-based diagnostics utilize the programmable RNA-guided DNA or RNA-targeting activity of CAS enzymes. When combined with a guide RNA (gRNA) complementary to a target sequence, these enzymes can be designed to bind specifically to and recognize the target nucleic acid. The diagnostic application combines this highly specific recognition with a signal-generating mechanism. The CRISPR system's intrinsic programmability, via gRNA design, enables the facile development and deployment of diagnostic tests for various targets, from infectious disease pathogens and genetic mutations to cancer biomarkers.

CRISPR-Based Diagnostics Market- Market Dynamics

The market for CRISPR-based diagnostics is driven by the rising global infectious disease burden, with an estimated over 10 million deaths yearly caused by infectious agents (as per WHO), requiring quick and precise diagnostic tools. Moreover, the rising incidence of genetic disorders and cancer globally drives the need for accurate diagnostic approaches for early detection and customized medicine. Genetic disorders have millions of victims worldwide, and cancer is a major cause of death, according to the National Institutes of Health (NIH). CRISPR diagnostics can potentially detect particular genetic mutations and biomarkers of cancer with high specificity. Point-of-care (POC) diagnostics are increasingly in demand due to a need for quick test results in resource-poor settings and decentralized testing. CRISPR-based assays can be modified for user-friendly POC devices, potentially transforming diagnostics in epidemic regions and during outbreaks.

Advances in technology in CRISPR systems, such as identifying new CAS enzymes with increased specificity and activity and advances in assay design and signal amplification methods, progressively enhance the ability and range of CRISPR-based diagnostics. The wide range of applications across different disease categories, from infectious diseases and genetic diseases to cancer, presents an enormous potential market. The capability to generate multiplexed assays to detect multiple targets within a single reaction in parallel is a huge advantage in economics and efficiency. In addition, the convergence of CRISPR diagnostics with microfluidics and other cutting-edge technologies can potentially create very sensitive and automated diagnostic platforms. Increased spending on research and development in genomics and diagnostics, including impressive government and private sector funding, continues to drive market expansion and innovation. However, the approval barriers and the requirement for standardization remain barriers to the universal take-up of these new technologies.

CRISPR-Based Diagnostics Market- Key Insights

Reagent and Kits segment is the largest as there is continuous requirement for consumables in CRISPR-based diagnostic assays. More research and diagnostic tests lead to a consistent demand for kits with guide RNAs, Cas enzymes, and other reagents required.

Cas9 has been the most studied and the most widely used Cas enzyme in CRISPR-based diagnostics as it has a well-characterized mechanism, which is well-stocked with tools and resources, and is highly versatile.

Hospital and Diagnostic labs are the largest consumers of CRISPR-based diagnostics because of their existing infrastructure, high-throughput testing capacity, and growing utilization of cutting-edge molecular diagnostic methods for the detection of a myriad of diseases.

Pharmaceutical and biotechnology firms are increasingly using CRISPR-based diagnostics to develop drugs, conduct clinical trials, and ensure quality control.

North America dominates the CRISPR-based diagnostics market with the largest share. This is due to the high presence of prominent research establishments, prominent biotechnology and pharmaceutical organizations, and high amounts of government funding dedicated to research in diagnostics and genomics in North America.

CRISPR-Based Diagnostics Market- Segmentation Analysis:

The Global CRISPR-Based Diagnostics Market is segmented on the basis of Product, Technology, Application, End-use, and Region.

By Technology, the market is segmented into Cas9, Cas12, and Others. The Cas9 segment has the largest market share. This is largely due to Cas9 being the most widely studied and best-understood CRISPR-associated enzyme. Its strong and promiscuous DNA targeting ability has rendered it the workhorse for numerous diagnostic applications developed in the nascent phase of the market. The availability of a large collection of tools, reagents, and well-standardized protocols based on Cas9 has permitted extensive applications in research and diagnostics development. Furthermore, early achievement and establishment of Cas9-based diagnostic tests have reasserted its dominant role. The Cas12 component is the fastest-developing in the market. This is driven by the special strengths provided by Cas12 enzymes, including their capacity to digest their crRNA arrays and unique ssDNA trans-cleavage activity. This latter ability can offer higher sensitivity and easier assay design than the Cas9-based approaches. The continuous identification of novel Cas12 variants with better properties and the growing investigation of their potential applications in point-of-care diagnosis drive their rapid growth rate.

Based on Application, the market is segmented into Infectious Disease Diagnostics, Genetic Disorder Diagnostics, Cancer Diagnostics, and Others. Infectious disease diagnostics is the largest share of the market. This is fueled by the global demand for quick & precise identification of infectious pathogens. CRISPR-based diagnostics' ability to be rapidly repurposed for the detection of new and emerging infectious agents, as seen during recent pandemics, places them in a vital role in outbreak control and enhanced patient care. Their potential for point-of-care diagnostics and high sensitivity in detecting even minimal viral or bacterial loads are other factors that help them rule this segment. Cancer diagnostics is the most rapidly growing segment in the market. This is driven by the rising global cancer burden and the imperative for earlier and more accurate diagnostic tools to deliver better patient outcomes. With great sensitivity and specificity, CRISPR technologies provide great promise for detecting cancer-specific biomarkers, including circulating tumor DNA (ctDNA) in liquid biopsies. This could revolutionize early cancer detection, treatment response monitoring, and personalized cancer therapy.

CRISPR-Based Diagnostics Market- Geographical Insights

North America has the biggest market share. The region's strong research base, many major biotechnology and pharma companies actively contributing to CRISPR technology advancement, and the huge amount of government support for genomics and diagnostic research are the reasons behind its dominance. The strong healthcare infrastructure and the high adoption rate of sophisticated molecular diagnostic methods in North America are also additional factors. The leading nations in this regional market are the US, a center of advanced research and commercialization, and Canada, with increasing emphasis on biotechnology and healthcare innovation. The Asia-Pacific region is expected to be the most rapidly developing market for CRISPR-Based Diagnostics. This growth is driven by various factors, such as the growing incidence of infectious diseases and genetic disorders in the region's huge population, an increase in healthcare spending, an increase in awareness and acceptance of sophisticated diagnostic technologies, and higher investments in research and development in nations such as China, India, and South Korea.

CRISPR-Based Diagnostics Market- Competitive Landscape:

The CRISPR-based diagnostics market is featured by a rapidly evolving and highly competitive environment involving a mix of established life science companies, focused diagnostic developers, and cutting-edge startups. Major players are involved in ongoing research and development activities aimed at broadening the utility of CRISPR technology in diagnostics, improving assay sensitivity and specificity, and creating convenient and point-of-care-based solutions. Strategic collaborations, partnerships, and licensing are common as companies try to capitalize on complementary abilities and facilitate product development and commercialization. The continuous identification of new CRISPR-Cas systems and new assay formats further heightens the competitive pressure. Companies differentiate themselves based on product innovation, technological innovation, collaborations, and intelligent navigation of regulatory pathways. Developing aggressive, reliable, and scalable CRISPR-based diagnostic platforms for various applications like infectious diseases, cancer, and genetic disorders is a leitmotif in this new competitive environment.

Recent Developments:

October 2024: Mammoth Biosciences and Integrated DNA Technologies, Inc. (IDT) have partnered to co-develop and market new CRISPR-based diagnostic products. This collaboration will leverage Mammoth Biosciences' new CRISPR enzymes with IDT's nucleic acid synthesis and manufacturing capabilities to develop highly sensitive and scalable diagnostic tests for different applications.

January 2023: Thermo Fisher Scientific Inc. signed an agreement to license Caribou Biosciences' intellectual property related to using Caribou's Cas12a for developing novel diagnostic products. Under this agreement, Thermo Fisher can further enhance its molecular diagnostics portfolio by adding the distinctive strengths of Cas12a enzymes.

September 2023: ToolGen Inc. obtained a regulatory nod in South Korea for its CRISPR-based diagnostic kit, which is used to identify a particular genetic mutation related to a rare inherited condition. ToolGen reached a major milestone, proving the potential of CRISPR technology in identifying genetic diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Molbio Diagnostics
  • Horizon Discovery
  • Synthego Corporation
  • Mammoth Biosciences
  • Sherlock Biosciences
  • Caribou Biosciences
  • CRISPRBits
  • ToolGen Inc.

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Enzymes
  • Kits and Reagents
  • Software and Libraries

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Cas9
  • Cas12
  • Others

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Diagnostics
  • Genetic Disorder Diagnostics
  • Cancer Diagnostics
  • Others

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics Diagnostic
  • Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Crispr-Based Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Crispr-Based Diagnostics Market Snippet By Product
    • 2.1.2. Crispr-Based Diagnostics Market Snippet By Technology
    • 2.1.3. Crispr-Based Diagnostics Market Snippet By Application
    • 2.1.4. Crispr-Based Diagnostics Market Snippet By End Use
    • 2.1.5. Crispr-Based Diagnostics Market Snippet by Country
    • 2.1.6. Crispr-Based Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Crispr-Based Diagnostics Key Market Trends

  • 3.1. Crispr-Based Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Crispr-Based Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Crispr-Based Diagnostics Market Opportunities
  • 3.4. Crispr-Based Diagnostics Market Future Trends

4. Crispr-Based Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Crispr-Based Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Crispr-Based Diagnostics Market Landscape

  • 6.1. Crispr-Based Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Crispr-Based Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Enzymes
    • 7.1.3. Kits and Reagents
    • 7.1.4. Software and Libraries

8. Crispr-Based Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Cas9
    • 8.1.3. Cas12
    • 8.1.4. Others

9. Crispr-Based Diagnostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Infectious Disease Diagnostics
    • 9.1.3. Genetic Disorder Diagnostics
    • 9.1.4. Cancer Diagnostics
    • 9.1.5. Others

10. Crispr-Based Diagnostics Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Hospitals and Clinics Diagnostic
    • 10.1.3. Laboratories
    • 10.1.4. Pharmaceutical and Biotechnology Companies
    • 10.1.5. Others

11. Crispr-Based Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Crispr-Based Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Crispr-Based Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Crispr-Based Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Crispr-Based Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Crispr-Based Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Crispr-Based Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. Integrated DNA Technologies, Inc.
    • 12.2.3. Molbio Diagnostics
    • 12.2.4. Horizon Discovery
    • 12.2.5. Synthego Corporation
    • 12.2.6. Mammoth Biosciences
    • 12.2.7. Sherlock Biosciences
    • 12.2.8. Caribou Biosciences
    • 12.2.9. CrisprBits
    • 12.2.10. ToolGen Inc.

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us